| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |